What is the share price of Gujarat Inject Kerala Ltd (GUJINJEC) today?
The share price of GUJINJEC as on 3rd July 2026 is ₹130.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Gujarat Inject Kerala Ltd (GUJINJEC) share?
The past returns of Gujarat Inject Kerala Ltd (GUJINJEC) share are- Past 1 week: 3.07%
- Past 1 month: 19.00%
- Past 3 months: 63.26%
- Past 6 months: 253.78%
- Past 1 year: 429.96%
- Past 3 years: 1335.31%
- Past 5 years: 5286.83%
What are the peers or stocks similar to Gujarat Inject Kerala Ltd (GUJINJEC)?
The peers or stocks similar to Gujarat Inject Kerala Ltd (GUJINJEC) include:What is the market cap of Gujarat Inject Kerala Ltd (GUJINJEC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Inject Kerala Ltd (GUJINJEC) is ₹191.76 Cr as of 3rd July 2026.What is the 52 week high and low of Gujarat Inject Kerala Ltd (GUJINJEC) share?
The 52-week high of Gujarat Inject Kerala Ltd (GUJINJEC) is ₹136.40 and the 52-week low is ₹19.01.Which sector does Gujarat Inject Kerala Ltd (GUJINJEC) belong to?
Gujarat Inject Kerala Ltd (GUJINJEC) belongs to the Materials sector & Diversified Chemicals sub-sector.How to buy Gujarat Inject Kerala Ltd (GUJINJEC) shares?
You can directly buy Gujarat Inject Kerala Ltd (GUJINJEC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Gujarat Inject Kerala Ltd
GUJINJEC Share Price
BSE₹130.904.97% (+6.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GUJINJEC Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GUJINJEC Performance & Key Metrics
GUJINJEC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | — | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 24.23 | — | 0.00% |
GUJINJEC Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GUJINJEC Company Profile
Gujarat Inject (Kerala) Limited is involved in the manufacture of other chemical products. The Company operates in India.
PIDILITIND
PE Ratio
66.41
66.41
1Y Return
2.62%
2.62%
Buy Reco %
78.95
78.95
SRF
PE Ratio
45.13
45.13
1Y Return
13.54%
13.54%
Buy Reco %
66.67
66.67
GODREJIND
PE Ratio
32.85
32.85
1Y Return
4.38%
4.38%
Buy Reco %
0.00
0.00
PIIND
PE Ratio
30.39
30.39
1Y Return
37.57%
37.57%
Buy Reco %
36.36
36.36
ATUL
PE Ratio
28.48
28.48
1Y Return
13.22%
13.22%
Buy Reco %
72.73
72.73
GUJINJEC Forecast
GUJINJEC Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GUJINJEC
GUJINJEC
Income
Balance Sheet
Cash Flow
Quarterly Normal View
GUJINJEC Income Statement
GUJINJEC Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.25 | 5.42 | 3.05 | 8.78 | 3.15 | 4.25 | 2.42 | 1.63 | 1.76 | 30.70 | ||||||||||
Operating & Other expenses | 0.25 | 5.37 | 2.88 | 8.07 | 2.87 | 4.15 | 2.32 | 1.54 | 1.71 | 28.43 | ||||||||||
EBITDA | 0.00 | 0.05 | 0.17 | 0.71 | 0.28 | 0.10 | 0.10 | 0.09 | 0.05 | 2.27 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | 0.00 | 0.05 | 0.17 | 0.71 | 0.28 | 0.10 | 0.10 | 0.09 | 0.05 | 2.27 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 0.00 | 0.05 | 0.17 | 0.71 | 0.28 | 0.10 | 0.10 | 0.09 | 0.05 | 2.27 | ||||||||||
| Taxes & Other Items | 0.00 | 0.01 | 0.04 | 0.10 | 0.07 | 0.03 | 0.02 | 0.02 | 0.01 | 0.63 | ||||||||||
| Net Income | 0.00 | 0.04 | 0.13 | 0.61 | 0.21 | 0.07 | 0.08 | 0.07 | 0.04 | 1.64 | ||||||||||
| EPS | 0.01 | 0.03 | 0.08 | 0.42 | 0.14 | 0.05 | 0.05 | 0.05 | 0.03 | 1.12 |
GUJINJEC Company Updates
GUJINJEC Stock Peers
GUJINJEC Past Performance & Peer Comparison
GUJINJEC Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsDiversified Chemicals
Compare valuation on Screener
MaterialsDiversified Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Gujarat Inject Kerala Ltd | 105.36 | — | — |
| Pidilite Industries Ltd | 66.41 | — | — |
| SRF Ltd | 45.13 | — | — |
| Godrej Industries Ltd | 32.85 | — | — |
GUJINJEC Stock Price Comparison
Compare GUJINJEC with any stock or ETFCompare GUJINJEC with any stock or ETF
GUJINJEC
GUJINJEC Holdings
GUJINJEC Shareholdings
GUJINJEC Promoter Holdings Trend
GUJINJEC Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
GUJINJEC Institutional Holdings Trend
GUJINJEC Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GUJINJEC Shareholding Pattern
GUJINJEC Shareholding Pattern
GUJINJEC Shareholding History
GUJINJEC Shareholding History
Foreign Institutions
smallcases containing GUJINJEC stock
smallcases containing GUJINJEC stock
Looks like this stock is not in any smallcase yet.
GUJINJEC Events
GUJINJEC Events
GUJINJEC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GUJINJEC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GUJINJEC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GUJINJEC has not given any dividends in last 5 years
GUJINJEC Dividends
GUJINJEC Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGUJINJEC Stock News & Opinions
GUJINJEC Stock News & Opinions
Articles & Videos
Spotlight
Spotlight
Gujarat Inject Kerala hits the roof after securing Rs 1-cr solar module orderThe order is for the supply of 1,334 units of 600Wp solar PV modules and is scheduled to be executed by June 2026. The company clarified that the transaction does not qualify as a related-party transaction and that neither its promoters nor promoter group entities have any interest in the contract. Gujarat Inject (Kerala) was initially a joint-sector venture to manufacture intravenous fluids but now primarily engaged in the trading of goods. The company, promoted by Gujarat Inject Limited and the Kerala State Industrial Development Corporation, transitioned from pharmaceutical production to textile trading, focusing on integrity and stakeholder responsibility. On the financial front, the company reported a standalone net profit of Rs 1.64 crore in Q4 FY26, compared with Rs 0.07 crore in the corresponding quarter of the previous year. Revenue from operations surged 624.1% year-on-year to Rs 30.70 crore during the quarter. Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Earnings
Gujarat Inject (Kerala) standalone net profit rises 2242.86% in the March 2026 quarterNet profit of Gujarat Inject (Kerala) rose 2242.86% to Rs 1.64 crore in the quarter ended March 2026 as against Rs 0.07 crore during the previous quarter ended March 2025. Sales rose 624.06% to Rs 30.70 crore in the quarter ended March 2026 as against Rs 4.24 crore during the previous quarter ended March 2025. For the full year,net profit rose 77.45% to Rs 1.81 crore in the year ended March 2026 as against Rs 1.02 crore during the previous year ended March 2025. Sales rose 90.66% to Rs 36.32 crore in the year ended March 2026 as against Rs 19.05 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales30.704.24 624 36.3219.05 91 OPM %7.392.12 -6.335.67 - PBDT2.270.10 2170 2.501.26 98 PBT2.270.10 2170 2.501.26 98 NP1.640.07 2243 1.811.02 77 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Gujarat Inject (Kerala) to discuss resultsGujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 20 May 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Gujarat Inject (Kerala) standalone net profit declines 80.95% in the December 2025 quarterNet profit of Gujarat Inject (Kerala) declined 80.95% to Rs 0.04 crore in the quarter ended December 2025 as against Rs 0.21 crore during the previous quarter ended December 2024. Sales declined 48.25% to Rs 1.63 crore in the quarter ended December 2025 as against Rs 3.15 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1.633.15 -48 OPM %-5.528.89 - PBDT0.050.28 -82 PBT0.050.28 -82 NP0.040.21 -81 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Gujarat Inject (Kerala) announces board meeting dateGujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
Gujarat Inject (Kerala) standalone net profit declines 88.52% in the September 2025 quarterNet profit of Gujarat Inject (Kerala) declined 88.52% to Rs 0.07 crore in the quarter ended September 2025 as against Rs 0.61 crore during the previous quarter ended September 2024. Sales declined 81.65% to Rs 1.58 crore in the quarter ended September 2025 as against Rs 8.61 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1.588.61 -82 OPM %1.906.27 - PBDT0.090.71 -87 PBT0.090.71 -87 NP0.070.61 -89 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Gujarat Inject (Kerala) to announce Quarterly ResultGujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Gujarat Inject (Kerala) to convene AGMGujarat Inject (Kerala) announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Earnings
Gujarat Inject (Kerala) standalone net profit declines 41.67% in the June 2025 quarterNet profit of Gujarat Inject (Kerala) declined 41.67% to Rs 0.07 crore in the quarter ended June 2025 as against Rs 0.12 crore during the previous quarter ended June 2024. Sales declined 20.66% to Rs 2.42 crore in the quarter ended June 2025 as against Rs 3.05 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2.423.05 -21 OPM %3.725.25 - PBDT0.090.16 -44 PBT0.090.16 -44 NP0.070.12 -42 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Gujarat Inject (Kerala) to hold board meetingGujarat Inject (Kerala) will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 349.06%, vs industry avg of 14.45%
Over the last 5 years, market share increased from 0% to 0.03%